Stay updated on Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.

Latest updates to the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page. This marks a newer build of the study details.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.6.4 was added, replacing v3.6.3 to reflect a newer page template release.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a new published version of the study page. This is a metadata update that does not modify the study content or results.SummaryDifference0.0%

- Check51 days agoChange DetectedA new page revision tag was released, upgrading from v3.6.0 to v3.6.2, indicating behind-the-scenes updates rather than changes to the study data presented on the page.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page now includes a recruitment status note indicating no further participants are being sought, and adds new help/navigation sections such as How to Read a Study Record, Common Questions, and How to Join a Study. It also features a formatting change to the Intervention/Treatment header and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check73 days agoChange DetectedA new revision label, Revision: v3.5.5, appears on the page. This indicates a minor update to the page’s documentation/versioning rather than a change to the study data or eligibility criteria.SummaryDifference0.0%

Stay in the know with updates to Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.